Valiant Laboratories Ltd (VALIANTLAB) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 10039033,
    "name": "Valiant Laborato",
    "stock_name": "Valiant Laborato",
    "full_name": "Valiant Laboratories Ltd",
    "name_url": "stocks-analysis/valiant-laborato",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "73.17",
    "chg": 8.08,
    "chgp": "12.41%",
    "dir": 1,
    "prev_price": "65.09",
    "mcapval": "397.40 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543998,
    "symbol": "VALIANTLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE0JWS01017",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "2.3 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/valiant-laborato-10039033-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Valiant Laboratories Stock Falls to 52-Week Low of Rs.64.23",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-laboratories-stock-falls-to-52-week-low-of-rs6423-3743777",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ValiantLaborato_priceRelatedfactors_3743777.png",
        "date": "2025-12-03 10:28:28",
        "description": "Valiant Laboratories, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.64.23, marking a significant price level for the stock amid a broader market environment that has seen mixed movements."
      },
      {
        "title": "Valiant Laboratories Stock Falls to 52-Week Low of Rs.64.23 Amid Market Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-laboratories-stock-hits-52-week-low-amidst-continued-downtrend-3743775",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ValiantLaborato_priceRelatedfactors_3743775.png",
        "date": "2025-12-03 10:28:18",
        "description": "Valiant Laboratories has reached a new 52-week low, with its stock price touching Rs.64.23 today. This marks a significant decline for the pharmaceutical and biotechnology company, reflecting ongoing challenges in its market performance and valuation metrics."
      },
      {
        "title": "Valiant Laboratories Stock Hits All-Time Low Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-laboratories-stock-hits-all-time-low-amidst-prolonged-downtrend-3743481",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ValiantLaborato_priceRelatedfactors_3743481.png",
        "date": "2025-12-03 09:59:43",
        "description": "Valiant Laboratories, a player in the Pharmaceuticals & Biotechnology sector, has reached an all-time low in its stock price, reflecting a sustained period of subdued market performance and financial metrics that highlight ongoing difficulties within the company."
      },
      {
        "title": "Valiant Laborato Sees Revision in Market Assessment Amid Challenging Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/valiant-laborato-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-technicals-3741172",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ValiantLaborato_mojoScore_3741172.png",
        "date": "2025-12-02 10:09:33",
        "description": "Valiant Laborato, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and technical outlook. The stock’s recent performance and fundamental indicators highlight a complex scenario for investors navigating this segment."
      },
      {
        "title": "Valiant Laboratories Stock Falls to 52-Week Low of Rs.66 Amidst Market Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-laboratories-stock-falls-to-52-week-low-of-rs-66-3735865",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ValiantLaborato_priceRelatedfactors_3735865.png",
        "date": "2025-11-28 15:46:08",
        "description": "Valiant Laboratories, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.66, marking a significant decline in its stock price amid subdued market conditions and sector underperformance."
      },
      {
        "title": "Valiant Laboratories Stock Falls to 52-Week Low of Rs.66 Amidst Market Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-laboratories-stock-falls-to-52-week-low-of-rs66-amidst-continued-downtrend-3735866",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ValiantLaborato_priceRelatedfactors_3735866.png",
        "date": "2025-11-28 15:45:58",
        "description": "Valiant Laboratories has reached a new 52-week low, with its share price touching Rs.66 today. This marks a significant decline for the pharmaceutical and biotechnology company, reflecting ongoing pressures in its market performance and valuation metrics."
      },
      {
        "title": "Valiant Laboratories Stock Hits All-Time Low Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-laboratories-stock-hits-all-time-low-amidst-prolonged-downtrend-3735823",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ValiantLaborato_priceRelatedfactors_3735823.png",
        "date": "2025-11-28 15:23:38",
        "description": "Valiant Laboratories, a player in the Pharmaceuticals & Biotechnology sector, has reached an all-time low in its stock price, reflecting a sustained period of subdued market performance and financial metrics that highlight ongoing pressures within the company."
      },
      {
        "title": "Valiant Laboratories Stock Falls to 52-Week Low of Rs.68.11",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-laboratories-stock-falls-to-52-week-low-of-rs6811-3733811",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ValiantLaborato_priceRelatedfactors_3733811.png",
        "date": "2025-11-27 14:44:40",
        "description": "Valiant Laboratories, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.68.11, marking a significant price level for the stock amid a broader market environment showing resilience."
      },
      {
        "title": "Valiant Laboratories Stock Hits All-Time Low Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-laboratories-stock-hits-all-time-low-amidst-prolonged-downtrend-3733793",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ValiantLaborato_priceRelatedfactors_3733793.png",
        "date": "2025-11-27 14:26:03",
        "description": "Valiant Laboratories, a player in the Pharmaceuticals & Biotechnology sector, has reached a new all-time low of Rs. 68.11, marking a significant point in its recent market performance. The stock’s decline contrasts sharply with broader market indices and sector trends, reflecting a challenging phase for the company."
      }
    ],
    "total": 263,
    "sid": "10039033",
    "stock_news_url": "https://www.marketsmojo.com/news/valiant-laboratories-10039033"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "13-Nov-2025",
      "details": "Copy of Newspaper Publication for Financial Results of Q2 FY 2025-26.",
      "source": "BSE"
    },
    {
      "caption": "Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30 2025.",
      "datetime": "11-Nov-2025",
      "details": "Audited Standalone and Consolidated Financial Results for the Quarter and Half Year ended September 30 2025.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Monitoring Agency Report",
      "datetime": "11-Nov-2025",
      "details": "Monitoring Agency Report for the quarter ended September 30 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Valiant Laboratories Ltd has announced <strong>1:4</strong> rights issue, ex-date: 18 Jul 25",
          "dt": "2025-07-18",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Valiant Laboratories Stock Falls to 52-Week Low of Rs.64.23

2025-12-03 10:28:28

Valiant Laboratories, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.64.23, marking a significant price level for the stock amid a broader market environment that has seen mixed movements.

Valiant Laboratories Stock Falls to 52-Week Low of Rs.64.23 Amid Market Pressure

2025-12-03 10:28:18

Valiant Laboratories has reached a new 52-week low, with its stock price touching Rs.64.23 today. This marks a significant decline for the pharmaceutical and biotechnology company, reflecting ongoing challenges in its market performance and valuation metrics.

Valiant Laboratories Stock Hits All-Time Low Amidst Prolonged Downtrend

2025-12-03 09:59:43

Valiant Laboratories, a player in the Pharmaceuticals & Biotechnology sector, has reached an all-time low in its stock price, reflecting a sustained period of subdued market performance and financial metrics that highlight ongoing difficulties within the company.

Valiant Laborato Sees Revision in Market Assessment Amid Challenging Fundamentals

2025-12-02 10:09:33

Valiant Laborato, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and technical outlook. The stock’s recent performance and fundamental indicators highlight a complex scenario for investors navigating this segment.

Valiant Laboratories Stock Falls to 52-Week Low of Rs.66 Amidst Market Pressure

2025-11-28 15:46:08

Valiant Laboratories, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.66, marking a significant decline in its stock price amid subdued market conditions and sector underperformance.

Valiant Laboratories Stock Falls to 52-Week Low of Rs.66 Amidst Market Pressure

2025-11-28 15:45:58

Valiant Laboratories has reached a new 52-week low, with its share price touching Rs.66 today. This marks a significant decline for the pharmaceutical and biotechnology company, reflecting ongoing pressures in its market performance and valuation metrics.

Valiant Laboratories Stock Hits All-Time Low Amidst Prolonged Downtrend

2025-11-28 15:23:38

Valiant Laboratories Stock Falls to 52-Week Low of Rs.68.11

2025-11-27 14:44:40

Valiant Laboratories, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.68.11, marking a significant price level for the stock amid a broader market environment showing resilience.

Valiant Laboratories Stock Hits All-Time Low Amidst Prolonged Downtrend

2025-11-27 14:26:03

Valiant Laboratories, a player in the Pharmaceuticals & Biotechnology sector, has reached a new all-time low of Rs. 68.11, marking a significant point in its recent market performance. The stock’s decline contrasts sharply with broader market indices and sector trends, reflecting a challenging phase for the company.

View All News